Log in

Relevant bibliographies by topics / Craigavon Area Hospital (Northern Ireland)

Contents

Journal articles
Books
Conference papers

Academic literature on the topic 'Craigavon Area Hospital (Northern Ireland)'

Author: Grafiati

Published: 4 June 2021

Last updated: 12 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Craigavon Area Hospital (Northern Ireland).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Craigavon Area Hospital (Northern Ireland)"

1

Egan, Sean. "James Bernard Walsh: Formerly Consultant Psychiatrist, Craigavon Area Hospital & St Lukes Hospital, Armagh, Northern Ireland." Psychiatric Bulletin 32, no. 7 (July 2008): 277. http://dx.doi.org/10.1192/pb.bp.108.021097.

Full text

Abstract:

James (Jim) Walsh was born on 25 August 1932 at Belleek on the Fermanagh–Donegal border. He showed early academic promise by winning a scholarship at St Columb's College, Derry, where he had commenced studies in 1945. By 1950 he had begun to study medicine at the Queen's University of Belfast, graduating in 1956, and completing his intern year at the Mater Infirmorum Hospital in Belfast.

APA, Harvard, Vancouver, ISO, and other styles

2

Kelly, C. B., J. Weir, T. Rafferty, and R. Galloway. "Deliberate self-poisoning presenting at a rural hospital in Northern Ireland 1976–1996: relationship to prescribing." European Psychiatry 15, no. 6 (September 2000): 348–53. http://dx.doi.org/10.1016/s0924-9338(00)00502-2.

Full text

Abstract:

summaryPurpose – This study reports on a project to monitor deliberate self-poisoning in a rural area of Northern Ireland over a 20-year period. Comparison is made with reports from large urban centres. In addition, a local prescribing database allows assessment of any association between psychotropic drug prescription and use for deliberate self-poisoning. Materials and methods – Frequency of self-poisoning, demographic details and drugs used were recorded for all episodes of deliberate self-poisoning occurring at Craigavon Area Hospital for the years 1976, 1986, 1991 and 1996. It was possible to compare prescriptions of psychotropic drugs with their use for deliberate self-poisoning between the years 1991 and 1996 in the region served by the hospital, using the Defined Daily Dose (DDD) system. Results – In this rural area the pattern of deliberate self-poisoning has changed, as in urban centres, with a rise in frequency and the male/female ratio approaching unity. The pattern of drug use has altered, with paracetamol overtaking benzodiazepines as the most commonly used agent. More recently, antidepressants have become the second most frequently used drug class for this purpose. Psychotropic medications used for self-poisoning altered in proportion to their prescription between the years 1991 and 1996. Conclusions – In the face of a continuing rise in deliberate self-poisoning, which is effecting both urban and rural areas, care should be taken to prescribe the least toxic agent available as this is associated with likely frequency of self-poisoning for most classes of psychotropic drug.

APA, Harvard, Vancouver, ISO, and other styles

3

McConnell, K. A. "702 A Retrospective Case Note Audit of Acute Asthma Admissions to the Paediatric Department, Craigavon Area Hospital, Northern Ireland." Pediatric Research 68 (November 2010): 356–57. http://dx.doi.org/10.1203/00006450-201011001-00702.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Corcoran, Paul, Eve Griffin, Amanda O’Carroll, Linda Cassidy, and Brendan Bonner. "Hospital-Treated Deliberate Self-Harm in the Western Area of Northern Ireland." Crisis 36, no. 2 (June 1, 2015): 83–90. http://dx.doi.org/10.1027/0227-5910/a000301.

Full text

Abstract:

Background: The Northern Ireland Registry of Deliberate Self-Harm was established as an outcome of the Northern Ireland Suicide Prevention Strategy and Action Plan – Protect Life, beginning in the Western Health and Social Care Trust area. Aims: The study aimed to establish the incidence of hospital-treated deliberate self-harm in the Western Area of Northern Ireland, and to explore the profile of such presentations. Method: Deliberate self-harm presentations made to the three hospital emergency departments operating in the area during the period 2007–2012 were recorded. Results: There were 8,175 deliberate self-harm presentations by 4,733 individuals. Respectively, the total, male, and female age-standardized incidence rate was 342, 320, and 366 per 100,000 population. City council residents had a far higher self-harm rate. The peak rate for women was among 15–19-year-olds (837 per 100,000) and for men was among 20–24-year-olds (809 per 100,000). Risk of repetition was higher in 35–44-year-old patients if self-cutting was involved, but was most strongly associated with the number of previous self-harm presentations. Conclusion: The incidence of hospital-treated self-harm in Northern Ireland is far higher than in the Republic of Ireland and more comparable to that in England.

APA, Harvard, Vancouver, ISO, and other styles

5

Grimason, Amy, and Adrian East. "A review of patients discharged from Shannon Clinic- are shorter stays in secure hospitals associated with poorer patient outcomes?" BJPsych Open 7, S1 (June 2021): S323. http://dx.doi.org/10.1192/bjo.2021.850.

Full text

Abstract:

AimsShannon Clinic was established as the regional secure unit in Northern Ireland in 2005 and provides medium secure care to Northern Ireland's population of 1.8 million. Previous research has shown that inpatient admissions are shorter when compared to other secure units. Northern Ireland has less secure beds per population than the other UK nations, which can be a driver for shorter hospital stays. This review was undertaken to examine if shorter inpatient stays were associated with poorer outcomes.MethodAll the discharges from Shannon Clinic to the Southern Health and Social Care Trust were reviewed over a period of 10 years (2009-2019). The outcome measures examined were mortality, readmission rate and reoffending rate. Crude rates for these were calculated. To allow for comparison, these rates were compared to the systematic review findings of Fazel et al (2016), which was an international review examining patient outcomes following discharge from secure hospitals.DUNDRUM 1 Triage Security scores for the patient group were also reviewed, to ensure a sample representative of patients needing medium secure care.Result41 patients had been discharged during this period. DUNDRUM 1 Triage Security scores ranged from 2.44 to 3.2.The average length of admission was 415.5 days. This is shorter than the average reported by Fazel et al (2016).The crude rates for all of the variables calculated (mortality, readmission to hospital and reoffending) for patients discharged from Shannon to the trust were less of those reported in the systematic review by Fazel et al (2016).ConclusionThis review suggests that patient outcomes are not negatively impacted by shorter inpatient stays in secure hospitals. A possible reason for this is the regional model of care approach, which helps ensure continuity and safe management of the transition between secure care and the community. In addition, there is close multidisciplinary working with supported living providers in the trust area to ensure patients' needs are met.Following this initial review, there are now plans to review discharge outcomes for all patients discharged during this period. There are five trust areas in total in Northern Ireland so this will allow for comparison across the region.The review has also been used within the unit to develop information leaflets for patients at admission and posters for display in the unit. We hope this will provide clarity to patients about secure care and a sense of optimism from the start of their admission.

APA, Harvard, Vancouver, ISO, and other styles

6

O'Shea, Rory, Declan Sheerin, Denise Canavan, and Vincent Russell. "Attitudes to visits by children to parents hospitalised with acute psychiatric illness." Irish Journal of Psychological Medicine 21, no. 2 (June 2004): 43–47. http://dx.doi.org/10.1017/s0790966700008260.

Full text

Abstract:

AbstractBackground: There is no published research on attitudes of psychiatrists towards children visiting parents who are acutely-unwell and inpatients in psychiatric hospitals. Nor is there information on facilities available for such visits.Objectives: (I) To assess the attitudes of Irish psychiatrists towards children visiting. (II) To determine the availability of child-friendly facilities within admission units.Method: A questionnaire was posted to every consultant psychiatrist accepting acute adult admissions in the Republic of Ireland and Northern Ireland.Results: The response rate was 69%. Ninty-seven per cent were in favour of children visiting. Almost half felt that decisions on visits should depend on the particular situation, considering the child, parent, ward, etc. However, only 11% of units had a room/area designated for children visiting. 90% had no facilities they considered child-friendly on their unit. A majority felt that arrangements for children visiting were inadequate.Conclusions: This topic is of interest to psychiatrists, and can be contentious, particularly when considering supervision of, and legal responsibility for, children visiting. Guidance on these issues would aid psychiatrists and hospital management. Poor facilities and infrequent visits may be a factor in the early development of stigma towards mental illness. Further research, improvements in facilities and staff training in liaison with children are needed.

APA, Harvard, Vancouver, ISO, and other styles

7

Paul, McCague, Brennan Hilary, and Wallace Scott. "P13 Medication use and excipient exposure in paediatrics in a secondary care setting." Archives of Disease in Childhood 103, no. 2 (January 19, 2018): e1.17-e1. http://dx.doi.org/10.1136/archdischild-2017-314584.24.

Full text

Abstract:

Background and aimPaediatric patients are widely exposed to a range of excipients which may cause harm to this vulnerable patient group. Legal requirement to disclose quantitative information on excipients changed in 2010,2 however, since most formulations were licensed prior to this date, there is a lack of potentially critical information available to currently practising pharmacists and clinicians. The aim of this study was to quantify excipient exposure to children in a secondary care setting.MethodA cohort study was conducted within Altnagelvin Area Hospital Paediatric Ward (Northern Ireland, Western Health and Social Care Trust) in January 2017. Medicines prescribed to patients throughout the study were recorded and exposure to ethanol, sodium benzoate and propylparaben was quantified.Exposure was then compared to proposed safe limits. Off-label and unlicensed use of medicines was assessed as a secondary aim. This study was classified as a service evaluation and ethical approval was not required.ResultsA total of 91 patients were enrolled in the study. Patient age ranged from 5 days to 15 years. The mean number of items prescribed per patient was 3.0. Analysis revealed that 75.8% of patients were exposed to ≥1 excipient of interest including ethanol, sodium benzoate and propylparabens. Excipient safety levels as proposed by the European Medicines Agency or World Health Organisation (where available) were not exceeded.Quantitative excipient information were not available for two products. There was both off-label and unlicensed use ofmedicines, with off-label prescribing (9.6%) being more common than the use of unlicensed medicines (0.4%).ConclusionThe paediatric population is exposed to potentially harmful excipients contained in commonly prescribed medicines. Although exposure within this study falls within existing safety limits, further research into paediatric specific safe exposure limits are required. It is notable that despite contacting themanufacturer, quantitative excipient information were not available for two products. Safety limits when considered together with quantitative excipient information will allow clinicians to complete an informed risk-benefit analysis for paediatric patients.ReferencesTulec C. Paediatric formulations in practice. In Costello I, Long PF, Wong IK, Tulec C, Yeung V (Ed.), Paediatric drug handling 2007:pp. 43–74. London: Pharmaceutical Press.European Commission. A guideline on summary of product characteristics [Online]2009;2:1–29. http://ec.europa.eu/health//sites/health/files/files/eudralex/vol-2/c/smpc_guideline_rev2_en.pdf [Accessed: 14th April 2017].

APA, Harvard, Vancouver, ISO, and other styles

8

Böing, Sebastian. "Schweres Asthma: Vergleich einer Typ-2-Biomarkerstrategie mit einem Symptom-basierten Algorithmus zur Steuerung der Kortisondosis." Kompass Pneumologie 9, no. 4 (2021): 185–86. http://dx.doi.org/10.1159/000517864.

Full text

Abstract:

<b>Background:</b> Asthma treatment guidelines recommend increasing corticosteroid dose to control symptoms and reduce exacerbations. This approach is potentially flawed because symptomatic asthma can occur without corticosteroid responsive type-2 (T2)-driven eosinophilic inflammation, and inappropriately high-dose corticosteroid treatment might have little therapeutic benefit with increased risk of side-effects. We compared a biomarker strategy to adjust corticosteroid dose using a composite score of T2 biomarkers (fractional exhaled nitric oxide [FENO], blood eosinophils, and serum periostin) with a standardised symptom-risk-based algorithm (control). <b>Methods:</b> We did a single-blind, parallel group, randomised controlled trial in adults (18–80 years of age) with severe asthma (at treatment steps 4 and 5 of the Global Initiative for Asthma) and FENO of less than 45 parts per billion at 12 specialist severe asthma centres across England, Scotland, and Northern Ireland. Patients were randomly assigned (4:1) to either the biomarker strategy group or the control group by an online electronic case-report form, in blocks of ten, stratified by asthma control and use of rescue systemic steroids in the previous year. Patients were masked to study group allocation throughout the entirety of the study. Patients attended clinic every 8 weeks, with treatment adjustment following automated treatment-group-specific algorithms: those in the biomarker strategy group received a default advisory to maintain treatment and those in the control group had their treatment adjusted according to the steps indicated by the trial algorithm. The primary outcome was the proportion of patients with corticosteroid dose reduction at week 48, in the intention-to-treat (ITT) population. Secondary outcomes were inhaled corticosteroid (ICS) dose at the end of the study; cumulative dose of ICS during the study; proportion of patients on maintenance oral corticosteroids (OCS) at study end; rate of protocol-defined severe exacerbations per patient year; time to first severe exacerbation; number of hospital admissions for asthma; changes in lung function, Asthma Control Questionnaire-7 score, Asthma Quality of Life Questionnaire score, and T2 biomarkers from baseline to week 48; and whether patients declined to progress to OCS. A secondary aim of our study was to establish the proportion of patients with severe asthma in whom T2 biomarkers remained low when corticosteroid therapy was decreased to a minimum ICS dose. This study is registered with ClinicalTrials.gov, NCT02717689 and has been completed. <b>Findings:</b> Patients were recruited from Jan 8, 2016, to July 12, 2018. Of 549 patients assessed, 301 patients were included in the ITT population and were randomly assigned to the biomarker strategy group (n = 240) or to the control group (n = 61). 28.4% of patients in the biomarker strategy group were on a lower corticosteroid dose at week 48 compared with 18.5% of patients in the control group (adjusted odds ratio [aOR] 1.71 [95% CI 0.80–3.63]; p = 0.17). In the per-protocol (PP) population (n = 121), a significantly greater proportion of patients were on a lower corticosteroid dose at week 48 in the biomarker strategy group (30.7% of patients) compared with the control group (5.0% of patients; aOR 11.48 [95% CI 1.35–97.83]; p = 0.026). Patient choice to not follow treatment advice was the principle reason for loss to PP analysis. There was no difference in secondary outcomes between study groups and no loss of asthma control among patients in the biomarker strategy group who reduced their corticosteroid dose. <b>Interpretation:</b> Biomarker-based corticosteroid adjustment did not result in a greater proportion of patients reducing corticosteroid dose versus control. Understanding the reasons for patients not following treatment advice in both treatment strategies is an important area for future research. The prevalence of T2 biomarker-low severe asthma was low. <b>Funding</b>: This study was funded, in part, by the Medical Research Council UK.

APA, Harvard, Vancouver, ISO, and other styles

9

Burns, Frances, Mische McKelvie, Sharon Cruise, and Dermot O'Reilly. "Using record linkage to test representativeness of an ageing cohort." International Journal of Population Data Science 4, no. 3 (November 21, 2019). http://dx.doi.org/10.23889/ijpds.v4i3.1265.

Full text

Abstract:

Background with rationaleThe numbers of older people are rising faster than any other group in society and Governments need to develop policies that will help older people stay as healthy and independent as possible for as long as possible. To do this they need to know what shapes the lives and health of older people and how they respond to their changing social, financial and health circumstances. Many countries are now investing in large and expensive ageing cohorts as omnibus studies to better understand the ageing processes and perhaps indicate how society can best prepare for an ageing population. These ageing cohorts (of people aged 50 and over) are invariably drawn from population-wide sampling frames and claim to be representative of the older populations, despite limitations in the sampling frame and modest response rates. AimThe aim of this study was to examine the representativeness of the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA) cohort through linkage to administrative health and demographic data. Specifically, to determine if there were any age, sex, or area of residence differences in NICOLA participants and whether they were healthier than the rest of the population in terms of recent hospital attendance or proximity to care home admission and/or death. Logistic regression will be used to compare characteristics of participants and the rest of the Northern Ireland population aged 50 and over. Data/MethodsAn identifier for each of the 8504 NICOLA Wave 1 participants was attached to the Health-card registration system which contains the HCN (the unique identifier) and thence to databases holding hospital admissions, mortality records and admissions to a care home. ResultsThe data are currently in the safe setting, with analysis starting this week, and results expected early autumn.

APA, Harvard, Vancouver, ISO, and other styles

10

Gregory, William J., Hannah Chambers, and Carol McCrum. "P085 The development of a UK-wide rheumatology specialist physiotherapy capabilities framework." Rheumatology 60, Supplement_1 (April 1, 2021). http://dx.doi.org/10.1093/rheumatology/keab247.083.

Full text

Abstract:

Abstract Background/Aims Rheumatology physiotherapy is a specialist area requiring specific skills and knowledge. At all levels of practice, physiotherapists play an essential role in patient management. There is not yet any profession-specific competency guidance in this area. The aim of this paper is to describe the processes undertaken in creating and reviewing a national rheumatology physiotherapy competency framework suitable for all levels of practice. Methods A national survey of rheumatology physiotherapy practice was completed in October 2019. At the end of the survey participants were invited to be involved in the development of a rheumatology physiotherapy competency and capabilities framework. Forty-seven physiotherapists expressed an interest and were invited to comment, critique and feedback on a draft rheumatology specialist competency framework document that had been developed in parallel to the survey. Results Twenty-five physiotherapists provided feedback on Version 1 of the draft framework. Responses were received from bands 6 - 8 post holders and from NHS and private provider work settings. Involvement was sought and received from the four nations of the UK: England, Northern Ireland, Scotland and Wales. For the 465 competencies within the draft framework, over 1,000 comments were received. These comments were reviewed and amalgamated into a Version 2 framework. Agreement level of the expert reviewers’ opinions on these competencies was generally high. In addition to competency statement specific feedback, general comments on content, aims, impacts and utility of the document were also received which informed the revisions undertaken. Version 2 reflects the expert input and constructive, excellent advice received. Themes within general comments included: defining expert speciality practice; focus on what is unique about Rheumatology for a physiotherapist; impacts and considerations from location of service delivery, e.g. primary versus secondary care, urban versus rural, large teaching hospital versus district general hospital; rotational versus non-rotational posts; enough authority of the final framework to support the need for funding in training and development, as well as leading to new roles; breadth and variability required within single post-holders; addressing blurred lines, unrecognised capabilities and supporting career progression; justification for working at a higher level than given credit. Conclusion There is a strong desire amongst the rheumatology physiotherapy profession to progress this project and to engage with and support the development of a national rheumatology physiotherapy competency framework. Many specialist physiotherapists have contributed their expertise in their own time to agree competency statements. The process has ratified the further development and future publication of this framework. Disclosure W.J. Gregory: Honoraria; W.G. has received honoraria from Abbvie, Pfizer and UCB. H. Chambers: None. C. McCrum: Honoraria; C.McC. has received honoraria from Novartis.

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Craigavon Area Hospital (Northern Ireland)"

1

O'Kane, John. Development of urology system for Craigavon Area Hospital Trust. (s.l: The Author), 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Magee, Seamus. Patients' and relatives' experiences of services provided at Craigavon Area Hospital. Portadown: Southern Health and Social Services Council, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Magee, Seamus. Women's voices: Women's experiences of maternity services at Craigavon Area Hospital following transfer from South Tyrone Hospital. Lurgan: Southern Health and Social Services Council, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Britain, Great. Health and personal social services: The Craigavon Area Hospital Group Health and Social Services Trust (Establishment) Order (Northern Ireland) 1992. Belfast: HMSO, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

The Craigavon and Banbridge Community Health and Social Services Trust (Establishment) (Amendment) Order (Northern Ireland) 1994 (Statutory Rule: 1994: 114). Stationery Office Books, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Britain, Great. Health and personal social services: The Craigavon and Banbridge Community Health and Social Services Trust (Establishment) Order (Northern Ireland) 1993. Belfast: HMSO, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Health and personal social services: The Craigavon and Banbridge Community Health and Social Services Trust (Establishment) (Amendment) Order (Northern Ireland) 1994. Belfast: HMSO, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

The Northern Ireland Guardian AD Litem Agency (Establishment and Constitution) Order (Northern Ireland) 1995 (Statutory Rule: 1995: 397). Stationery Office Books, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

The Northern Ireland Blood Transfusion Service (Special Agency) (Establishment and Constitution) Order (Northern Ireland) 1994 (Statutory Rule: 1994: 175). Stationery Office Books, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Health and personal social services: The Northern Ireland Guardian ad Litem Agency (Establishment and Constitution) Order (Northern Ireland) 1995. Belfast: HMSO, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Conference papers on the topic "Craigavon Area Hospital (Northern Ireland)"

1

Peace, A., P. Hegarty, M. McGrellis, and A. McNeill. "32 Nurse-led dc cardioversion service at altnagelvin area hospital." In Irish Cardiac Society Annual Scientific Meeting & AGM, Thursday October 5th – Saturday October 7th 2017, Millennium Forum, Derry∼Londonderry, Northern Ireland. BMJ Publishing Group Ltd and British Cardiovascular Society, 2017. http://dx.doi.org/10.1136/heartjnl-2017-ics17.32.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Aleong, G., A. Peace, Z. Sharif, R. Tanner, S. Abdallah, S. David, A. McNeill, and J. Crowley. "28 Initial experience of donegal cross border program between letterkenny university hospital (roi) and altnagelvin area hospital (ni)." In Irish Cardiac Society Annual Scientific Meeting & AGM, Thursday October 5th – Saturday October 7th 2017, Millennium Forum, Derry∼Londonderry, Northern Ireland. BMJ Publishing Group Ltd and British Cardiovascular Society, 2017. http://dx.doi.org/10.1136/heartjnl-2017-ics17.28.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!